UBS analyst Kevin Mcveigh upgrades Accenture (NYSE:ACN) from Neutral to Buy and maintains the price target from $400 to $400.
UBS Upgrades Accenture to Buy, Maintains Price Target to $400
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.